Literature DB >> 12843108

Use of amplified ribosomal DNA restriction analysis for identification of Ralstonia and Pandoraea species: interest in determination of the respiratory bacterial flora in patients with cystic fibrosis.

Christine Segonds1, Sandrine Paute, Gérard Chabanon.   

Abstract

The recovery of Ralstonia and Pandoraea species from respiratory tract cultures of patients with cystic fibrosis has recently been reported. These species are difficult to identify, and especially to differentiate from Burkholderia cepacia complex organisms, with classical methods. The discriminatory power of amplified ribosomal DNA restriction analysis (ARDRA) within the two genera was assessed by comparing the restriction profiles of reference strains of each species by using a panel of six enzymes already proven suitable for the identification of Burkholderia species. ARDRA provided differentiation of all the Ralstonia species tested and of Pandoraea norimbergensis. Pandoraea species P. pnomenusa, P. sputorum, P. pulmonicola, and P. apista were not discriminated to the species level. This method allowed the identification of five clinical isolates recovered from French cystic fibrosis patients as Ralstonia mannitolilytica.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843108      PMCID: PMC165356          DOI: 10.1128/JCM.41.7.3415-3418.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  One case each of recurrent meningitis and hemoperitoneum infection with Ralstonia mannitolilytica.

Authors:  M Vaneechoutte; T De Baere; G Wauters; S Steyaert; G Claeys; D Vogelaers; G Verschraegen
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex.

Authors:  Sylvain Brisse; Stefania Stefani; Jan Verhoef; Alex Van Belkum; Peter Vandamme; Wil Goessens
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  Genome sequence of the plant pathogen Ralstonia solanacearum.

Authors:  M Salanoubat; S Genin; F Artiguenave; J Gouzy; S Mangenot; M Arlat; A Billault; P Brottier; J C Camus; L Cattolico; M Chandler; N Choisne; C Claudel-Renard; S Cunnac; N Demange; C Gaspin; M Lavie; A Moisan; C Robert; W Saurin; T Schiex; P Siguier; P Thébault; M Whalen; P Wincker; M Levy; J Weissenbach; C A Boucher
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

4.  Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays.

Authors:  T Coenye; L Liu; P Vandamme; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Case of catheter sepsis with Ralstonia gilardii in a child with acute lymphoblastic leukemia.

Authors:  G Wauters; G Claeys; G Verschraegen; T De Baere; E Vandecruys; L Van Simaey; C De Ganck; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Classification of metal-resistant bacteria from industrial biotopes as Ralstonia campinensis sp. nov., Ralstonia metallidurans sp. nov. and Ralstonia basilensis Steinle et al. 1998 emend.

Authors:  J Goris; P De Vos; T Coenye; B Hoste; D Janssens; H Brim; L Diels; M Mergeay; K Kersters; P Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2001-09       Impact factor: 2.747

7.  Ralstonia taiwanensis sp. nov., isolated from root nodules of Mimosa species and sputum of a cystic fibrosis patient.

Authors:  W M Chen; S Laevens; T M Lee; T Coenye; P De Vos; M Mergeay; P Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2001-09       Impact factor: 2.747

8.  Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates.

Authors:  C Segonds; T Heulin; N Marty; G Chabanon
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

9.  Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov.

Authors:  T Coenye; E Falsen; B Hoste; M Ohlén; J Goris; J R Govan; M Gillis; P Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2000-03       Impact factor: 2.747

10.  Use of the gyrB gene for the identification of Pandoraea species.

Authors:  Tom Coenye; John J LiPuma
Journal:  FEMS Microbiol Lett       Date:  2002-02-19       Impact factor: 2.742

View more
  10 in total

1.  Intrinsic carbapenem-hydrolyzing oxacillinases from members of the genus Pandoraea.

Authors:  Ines Schneider; Adolf Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

2.  Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis.

Authors:  Raphaël Chiron; Hélène Marchandin; François Counil; Estelle Jumas-Bilak; Anne-Marie Freydière; Gabriel Bellon; Marie-Odile Husson; Dominique Turck; François Brémont; Gérard Chabanon; Christine Segonds
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients.

Authors:  Nicolas Degand; Etienne Carbonnelle; Brunhilde Dauphin; Jean-Luc Beretti; Muriel Le Bourgeois; Isabelle Sermet-Gaudelus; Christine Segonds; Patrick Berche; Xavier Nassif; Agnès Ferroni
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

4.  Chronic colonization with Pandoraea apista in cystic fibrosis patients determined by repetitive-element-sequence PCR.

Authors:  R M Atkinson; J J Lipuma; D B Rosenbluth; W M Dunne
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

5.  Misidentification of Pandoraea sputorum isolated from sputum of a patient with cystic fibrosis and review of Pandoraea species infections in transplant patients.

Authors:  Jason D Pimentel; Colin MacLeod
Journal:  J Clin Microbiol       Date:  2008-07-23       Impact factor: 5.948

6.  Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis.

Authors:  Atqah AbdulWahab; Saad J Taj-Aldeen; Emad Bashir Ibrahim; Eman Talaq; Marawan Abu-Madi; Rashmi Fotedar
Journal:  Infect Drug Resist       Date:  2015-04-30       Impact factor: 4.003

7.  Complete Genome Sequence Analysis of Pandoraea pnomenusa Type Strain DSM 16536(T) Isolated from a Cystic Fibrosis Patient.

Authors:  Yan-Lue Lim; Robson Ee; Delicia Yong; Choo-Yee Yu; Geik-Yong Ang; Kok-Keng Tee; Wai-Fong Yin; Kok-Gan Chan
Journal:  Front Microbiol       Date:  2016-02-08       Impact factor: 5.640

8.  In vitro activity of 20 antibiotics against Cupriavidus clinical strains.

Authors:  Clémence Massip; Mathieu Coullaud-Gamel; Cécile Gaudru; Lucie Amoureux; Anne Doleans-Jordheim; Geneviève Hery-Arnaud; Hélène Marchandin; Eric Oswald; Christine Segonds; Hélène Guet-Revillet
Journal:  J Antimicrob Chemother       Date:  2020-06-01       Impact factor: 5.790

9.  Meropenem-Resistant Pandoraea Pneumonia in a Critically Ill Patient With COVID-19.

Authors:  Mohammad M Dlewati; Pyi Phyo Aung; Kyeeun Park; Jose A Rodriguez; Kenneth K Poon
Journal:  Cureus       Date:  2021-11-12

10.  Epidemic spread of Pandoraea pulmonicola in a cystic fibrosis center.

Authors:  Nicolas Degand; Romain Lotte; Célia Decondé Le Butor; Christine Segonds; Michelle Thouverez; Agnès Ferroni; Christine Vallier; Laurent Mély; Jacqueline Carrère
Journal:  BMC Infect Dis       Date:  2015-12-26       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.